Lunai Bioworks
LNAI
27 hedge funds and large institutions have $403K invested in Lunai Bioworks in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
23% more funds holding
Funds holding: 22 → 27 (+5)
0.08% less ownership
Funds ownership: 0.59% → 0.51% (-0.08%)
59% less capital invested
Capital invested by funds: $982K → $403K (-$578K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$62.1K |
| 2 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
+$48.5K |
| 3 |
VF
Virtu Financial
New York
|
+$46.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$32.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$147K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$18.2K |
| 3 |
Jane Street
New York
|
-$10.5K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$6.09K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.04K |
LNAI Hedge Fund Activity: Q1 2026 in Review
27 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q1 2026, worth a combined $403K — down 59% from $982K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new LNAI positions and 4 closed out — a net gain of 6 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $62.1K. The largest seller was Millennium Management, exiting entirely with an estimated $147K sold.
- 27 institutional investors held Lunai Bioworks (LNAI) as of Q1 2026, up from 22 in Q4 2025.
- Funds reported $403K of Lunai Bioworks stock for Q1 2026, down 59% quarter-over-quarter.
- 10 funds opened new Lunai Bioworks positions in Q1 2026 and 4 closed out, a net change of +6 holders.
- The largest Lunai Bioworks buyer in Q1 2026 was Citigroup, an estimated $62.1K added.
- The largest Lunai Bioworks seller in Q1 2026 was Millennium Management, an estimated $147K sold.
Based on aggregated 13F filings for Q1 2026.